News

Arcus Biosciences, a US-based biotechnology company focused on the discovery and development of innovative cancer immunotherapies, announced that it has entered into an option and…
Read More...

FUJIFILM Diosynth Biotechnologies has announced its opening of the 10,000 square foot, state-of-the-art cell culture Process Development Laboratories in Wilton Centre, Teesside. These…
Read More...

Boehringer Ingelheim announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion for the Marketing…
Read More...

Ambry Genetics Corporation announces integration between their secure AmbryPort 2.0 (AP2) clinician ordering platform and FDNA’s Face2Gene® suite of applications. This integration is…
Read More...

Bristol-Myers Squibb Company and Halozyme Therapeutics, Inc. announced a global collaboration and license agreement to develop subcutaneously administered Bristol-Myers Squibb…
Read More...

MilliporeSigma announced that Celonic AG, a Swiss contract development and manufacturing organization (CDMO), is upgrading its manufacturing facility with five of MilliporeSigma's…
Read More...

Agilent Technologies Inc. has announced that it has obtained 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the GenetiSure Dx Postnatal Assay: its first…
Read More...

Evotec AG and MaRS Innovation announced the launch of "LAB150". This transformational Toronto-based partnership will give Canadian academic institutions and teaching hospitals access to…
Read More...

Bormioli Rocco Pharma is strengthening its services in North America for pharmaceutical glass packaging with a dedicated sales team and innovative products, particularly for high-value…
Read More...

HanAll Biopharma and Harbour BioMed announced that they have entered into a strategic collaboration and license agreement to develop, manufacture and commercialize in Greater China …
Read More...

Pascal Biosciences announced that the Company has executed an exclusive, worldwide license option agreement with STC.UNM (“STC”), the University of New Mexico’s technology-transfer and…
Read More...

AbCellera Biologics, Inc. announced that it has entered into an antibody discovery research collaboration with GSK, whereby AbCellera will apply its high-throughput single-cell antibody…
Read More...

Merck has announced that it will enter into a strategic collaboration with Project Data Sphere LLC, an independent, not-for-profit initiative of the CEO Roundtable on Cancer's Life…
Read More...

Adaptimmune Therapeutics plc announced that GlaxoSmithKline plc has exercised its option under a collaboration and license agreement signed in 2014 to exclusively license the right to…
Read More...

Vanderbilt University Medical Center (VUMC) and Bayer have agreed on a five-year strategic research alliance to evaluate new drug candidates for the treatment of kidney diseases, with…
Read More...

Kura Oncology announced positive topline results from a Phase 2 trial for its lead product candidate, tipifarnib, in patients with HRAS mutant relapsed or refractory squamous cell…
Read More...

IRX Therapeutics presented results from a Phase 2a clinical trial of IRX-2, the company’s lead drug candidate, in head and neck squamous cell carcinoma (SCCHN) at the European Society…
Read More...

Alcami Corporation announced the unveiling of its new analytical testing facility, located at 4260 Forest Park Avenue, in the Cortex Innovation Community, a 200-acre innovation hub and…
Read More...

HitGen Ltd announced that the company has entered into a research collaboration with Takeda Pharmaceutical Company Limited to discover novel small molecule leads for multiple targets in…
Read More...

Teva Pharmaceutical announced that it has entered into a definitive agreement under which CooperSurgical will acquire PARAGARD® (intrauterine copper contraceptive), a product within its…
Read More...